Assure (NASDAQ:IONM) vs. Profound Medical (NASDAQ:PROF) Head-To-Head Review

Assure (NASDAQ:IONM) and Profound Medical (NASDAQ:PROF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, analyst recommendations and earnings.

Institutional and Insider Ownership

3.3% of Assure shares are owned by institutional investors. Comparatively, 47.9% of Profound Medical shares are owned by institutional investors. 3.8% of Assure shares are owned by insiders. Comparatively, 1.5% of Profound Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Assure and Profound Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Assure	0	0	0	0	0.00
Profound Medical	0	0	3	1	3.25

Profound Medical has a consensus price target of $13.75, suggesting a potential upside of 89.66%. Given Profound Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Profound Medical is more favorable than Assure.

Valuation & Earnings

This table compares Assure and Profound Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Assure	$149,000.00	1.08	-$26.08 million	N/A	N/A
Profound Medical	$8.98 million	24.23	-$28.57 million	($1.34)	-5.41

Assure has higher earnings, but lower revenue than Profound Medical.

Risk & Volatility

Assure has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500. Comparatively, Profound Medical has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.

Profitability

This table compares Assure and Profound Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Assure	-25,178.32%	N/A	-249.78%
Profound Medical	-349.41%	-85.22%	-64.87%

Summary

Profound Medical beats Assure on 9 of the 13 factors compared between the two stocks.

About Assure

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. It offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures. The company delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures. Assure Holdings Corp. is based in Englewood, Colorado.

About Profound Medical

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.